Skip to main content
françaisFR
European Commission logo print header

The Development of an Innovative, Accurate, Monolithic, CVD Diamond Array based Radiation Dosimeter System

Objectif

Nearly 1 million Europeans die from cancer each year and 1 in 3 can expect to deal with a cancer episode in their lifetime. The cost of treatment in Europe is over ?50 billion and fighting the disease is a major EU priority. Radiotherapy is used in 50% of cases and recent advances in conformal radiotherapy techniques such as IMRT are significantly improving treatment success rates. However, conventional dosimetry techniques (ionisation chambers, silicon diodes etc) are not capable of delivering the high resolution, high speed measurements required for IMRT calibration. This leads to lengthy set-up times seriously limiting the number of patients that can be treated. This proposal will develop an innovative, high resolution, monolithic CVD diamond array based domsimeter which will deliver the levels of performance required by IMRT. There is no other commercially available technology that can offer this. The science and technology required to do this will be challenging, yet the partnership comprises some of Europe's leading research and industrial companies. Our innovations in i) CVD diamond deposition, (PIP), (ii) overcoming priming effects and sensor fabrication, (iii) ultra low signal signal conditioning electronics with a self evaluation system to monitor degradation will enable us to achieve our goals. The market potential for such a product is ?101 million. Unlike the world radiotherapy market which is dominated by the US (Varian-56% share) the dosimetry market is lead by European SMEs. However, this situation is being seriously threatened by large non-EU enterprises such as Varian, who are now targeting dosimetry. As European SMEs, we urgently need to beat our competition to an IMRT dosimtery solution to protect our market and enable us to compete against globalisation. This proposal brings togther a transnational partnership of research excellence and SME exploitation capability and is particularly relevant to the FP6 Cooperative Research programme...

Champ scientifique

Programme(s)

Thème(s)

Appel à propositions

FP6-2003-SME-1
Voir d’autres projets de cet appel

Régime de financement

COOPERATIVE -

Coordinateur

SEMELAB PLC
Contribution de l’UE
Aucune donnée
Adresse
Coventry Road
LUTTERWORTH
Royaume-Uni

Voir sur la carte
Coût total
Aucune donnée

Participants (10)

Partager cette page

Télécharger

Dernière mise à jour: 8 Mars 2013

Mon livret

Permalink: https://cordis.europa.eu/project/id/17573/fr

European Union, 2024